List, contact details, location and description of Blood Banks & Blood Transfusion Providers in Gurgaon.
The Blood Bank of Alchemist provides round the clock blood support and assures the supply of safe & quality blood to the patients. Standards in techniques and quality control are meticulously maintained as laid down in the Drugs and Cosmetics Act, by the regulatory authority, Directors Drug Controller (India), Ministry of Health & Family Welfare, Government of India to quality in all facets of Transfusion Services.
The FMRI transfusion medicine department provides 247 services and 100% voluntary blood collection and testing facilities that follows proper systems to ensure good quality of blood. We provide the following facilities: Whole Blood, Red Blood Cells, Platelets, Cryoprecipitated AHF and Fresh Frozen Plasma (FFP).
Blood Bank services deals with transfer of blood from one donor person to the recipient. Park Hospital has fully functional, most advanced Blood Bank available 24 x 7 with all the blood components. The aim of the department is to supply safest blood which is done by proper screening and examination of donor_s blood for HIV 1, HIV 2, Hepatitis B and C and Malaria antigen.
Blood Bank at the General Hospital, Gurgaon has a capacity of 300 Units.
Paras Hospital Blood Bank, Sushant Lok 1, Gurgaon has a capacity of 300 Units.
Blood Transfusion centre at Artemis is a first centre in South East Asia to adopt universal leucodepletion in routine practice. It is also the first center in India to have individual donor nucleic acid testing (ID-NAT) tested blood from center initiation. This centre is among very few centers to have patient tailored component therapy. The Blood transfusion services are backed by highly trained and dedicated staff to deliver the best clinical practices.
Leucodepletion :– Leucodepletion is a procedure that minimizes white blood cell (WBC) transmission in transfused blood. WBC’s are the most common contaminant in the blood and are known to cause various adverse effects such as:
Febrile non-hemolytic transfusion reactions – one of the most common transfusion associated complications that causes fevers and leads to stopping of the transfusion.
Transmission of viral infections such as Cytomegalovirus (CMV) that causes serious complications in newborns, transplant and immunocompromised patients.
Refractoriness to platelet transfusions. Platelet refractoriness is a major cause of problems in the long-term management of patients that are transfusion dependent such as chemotherapy and oncology patients.
In fact, 3-5 log leucodepletion is a standard clinical practice in developed countries and has been shown to improve patient outcomes and decrease hospital costs.
Individual Donor Nucleic Acid Testing: – Individual donor nucleic acid testing (ID-NAT) that is performed on donated blood dramatically improves the safety of blood transfusion by reducing the chances of transmission of HIV, hepatitis B (HBV) and hepatitis C (HCV). Most commonly used screening methods pick up these viruses by looking for antibodies which may develop only many months after acquiring the infection. ID-NAT reduces the window period by looking for viral DNA or RNA even before antibodies are formed. Thus, we can detect these infections at a very early stage, which is not possible with routine screening tests in most of the blood banks.
Blood Component Therapy
One donor can give one unit of whole blood. However, blood has many different living and non living parts that can be separated and stored.
This separation of blood is into what is known as blood components. Artemis Health Institute is among very few centers that performs this.
Only the portion of blood that is required by the patient is administered, thereby minimizing the risks of transfusion and allowing for efficient use of a donated whole blood unit.
Patient tailored blood component therapies are routinely practiced in developed countries taking into consideration the patient safety and compliances with current good clinical practice (cGMP)
Criteria for blood donation have also been defined to minimize risks to the donor. These criteria include:
Donor should be in good health. The minimum acceptable patient weight is =45 kg for whole blood donation and =55 kg for aphaeresis donation.
The hemoglobin level should be = 12.5 gm/dl.
Donor age should be between 18 – 60 years.
Donors are screened on basis of guidelines laid down by various bodies such as the Central Drug Controller of India under Drug and Cosmetic Act (DCA, 1940) and American Association of Blood Banks (AABB). Our highly trained staff in the blood bank will assist you throughout the screening and donation process.
Umkal hospital has fully modernized non invasive lab, a completely equipped ICU (Intensive Care Unit), a special cardiac lab along with a pathology lab and a blood bank.
Transfusion Medicine Specialists deal with the transfer of blood or blood products from one person (the donor) into another person’s (the recipient’s) bloodstream. Transfusion of your own blood (autologous) is the safest method but requires planning and not all patients are eligible. Directed donor blood allows the patient to receive blood from known donors. Volunteer donor blood is the safest.
The endeavour of the department is to supply safest possible blood components. The safety begins with diligent check of donor’s medical history and physical examination. The tests for HIV 1 & 2, Hepatitis B & C, Malaria and Syphilis are done using best of technology and methods. There is an additional layer of safety in testing called Nuclear Amplification Technology (NAT). There are few blood centres in the country which use this testing technology. There are advance technologies like Universal Leucodepletion, Irregular Antibody Screen, etc to reduce the chances of adverse reactions to the patient.
We perform therapeutic apheresis procedures in patients suffering from certain neurological disorders like Myasthenia gravis, G B Syndrome, etc. The department is also part of stem cell harvest, their cryopreservation and infusion as part of the stem cell therapy for variety of disorders.
Cryobanks International India a JV between Lifeforce Cryobanks International USA and RJ Corp founded in 2006. The company is focused on providing high-quality umbilical cord blood stem cell processing, and storage for both private and public donation purposes. Based at Gurgaon with networks in all the towns of India provides a high end processing and storage technology which are approved by International authorities. Cryobanks India has spread beyond the shores to Thailand,UAE,Nepal ,Bangladesh and East Africa making it the only India Cord Blood bank available in International Market. Cryobanks India has set up 28,000 square feet, state-of-the-art stem cell processing and banking facility in Gurgaon Haryana.
SGT Hospital’s Blood Bank has a capacity of 200 Units.